Global Cancer Therapeutics Market (2023-2028): Cancer Chemotherapy Dominates Market - A Closer Look at Therapeutic Types
07 sept. 2023 05h58 HE
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of...
TIGIT Inhibitors Revolutionize Immune System Control: A Comprehensive Analysis of Clinical Trials and Market Dynamics
06 sept. 2023 10h34 HE
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibody Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. The report...
Global Intratumoral Cancer Therapies Market Report 2023: Increasing Incidence of Cancer is Expected to Propel Growth
16 juin 2023 05h08 HE
|
Research and Markets
Dublin, June 16, 2023 (GLOBE NEWSWIRE) -- The "Intratumoral Cancer Therapies Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Checkpoint Inhibitors Clinical Trial Pipeline Appears Robust with 180+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight
10 mai 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 10, 2023 (GLOBE NEWSWIRE) -- Checkpoint Inhibitors Clinical Trial Pipeline Appears Robust with 180+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight The...
Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles
08 mai 2023 06h48 HE
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...
Global Checkpoint Inhibitors Market Report 2023: Rising Number of Cancer Cases Drives Growth
24 avr. 2023 13h18 HE
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth
15 déc. 2022 05h18 HE
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...
Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More
29 nov. 2022 08h08 HE
|
Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market, by Drug Class, By Cancer Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...
Worldwide Immuno-oncology Industry to 2028 - Featuring Novartis, Merck, Regeneron Pharmaceuticals and Pfizer Among Others
16 nov. 2022 04h18 HE
|
Research and Markets
Dublin, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The "Immuno-oncology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro
15 nov. 2022 04h00 HE
|
AKAMPION
- Promising data presented at Protein and Antibody Engineering Summit (PEGS) - Multi-functional agent targeting three immune checkpoint receptors - Potential as mono- and combination therapy for...